Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Lloyd Paul Aiello, M.D., PH.D.

TitleProfessor of Ophthalmology
InstitutionJoslin Diabetes Center
DepartmentOphthalmology
AddressJoslin Diabetes Center
One Joslin Place
Boston MA 02215
Phone617/732-2520
Fax617/732-2545

 Biography 
 awards and honors
1980 - Phi Lambda Upsilon
1988 - Alpha Omega Alpha, National Honor Medical Society
1988 - Sidney Cooperband Memorial Fund Award
1992 - 1993Heed Fellowship
1992 - 1993The Fellow of the Society of Heed Fellows
1993 - 1994Heed/Knapp Fellowship
1994 - 1996Capps Scholar in Diabetes
1994 - Marios C. Balodimos, MD Award
1994 - 1997Pfizer Postdoctoral Fellowship (diabetes/endocrinology)
1996 - Alcon Research Institute Award
1997 - 3rd Annual Irvine H. Leopold Lecture
1999 - American Academy of Ophthalmology Achievement Award
2000 - Dolly Green Scholar
2000 - Mary Jane Kugel Award
2002 - Richard and Hinda Rosenthal Foundation Award
2003 - Ministry of Health Higher Medical Development Expert Visitorship, Diabetic Eye Disease
2003 - Novartis Award in Diabetes - Young Investigator
2003 - Outstanding Foreign Investigator Award
2003 - Sir William Osler Young Investigator Award
2005 - 2nd Annual Anwar Shah Retina Lecturer
2005 - Inaugural Charles L. Schepens Research Award
2006 - Mary Jane Kugel Award
2006 - Paper of the Year Award in Telemedicine and E-health
2007 - Address to His Excellency Dr. APJ Abdul Kalam, Pres. of India and other dignitaries
2007 - Appointed Honorary Professor of Ophthalmology
2007 - ARVO/Pfizer Ophthalmics Translational Research Award
2007 - Award of Merit in Retina Research & the Charles L. Schepens Lecture
2007 - Irving H. Leopold Lecturer
2007 - Miembro Correspondiente
2007 - Senior Achievement Award
2007 - Special Research Scholar Award
2008 - 25th Annual David & Mary Seslen Lecturer
2008 - Best of the Posterior Segment Specialty Meetings 2008
2008 - Editors' Choice Symposiuim for "Rosiglitazone May Delay Onset of PDR". Arch. Ophthalmol.
2008 - Michael A. Wainstock, MD Endowed Lectureship
2009 - Fellow's Silver Medal
2009 - Paul Henkind Memorial Lecture
2010 - Lew R. Wasserman Merit Award
2010 - Best of Papers of the Posterior Segment Specialty Meetings 2010
2010 - Honorary Master Degree

 Research 
 research resources
This researcher has shared information about their research resources
in the eagle-i Network. To update or add resource records, contact
eagle-i@hms.harvard.edu.
Computer Resource (JDC) - Core services (2) and Software (4)

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Sun JK, Lin MM, Lammer J, Prager S, Sarangi R, Silva PS, Aiello LP. Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema. JAMA Ophthalmol. 2014 Nov 1; 132(11):1309-16.
    View in: PubMed
  2. Silva PS, Diala PA, Hamam RN, Arrigg PG, Shah ST, Murtha TL, Schlossman DK, Cavallerano JD, Sun JK, Aiello LP. Visual outcomes from pars plana vitrectomy versus combined pars plana vitrectomy, phacoemulsification, and intraocular lens implantation in patients with diabetes. Retina. 2014 Oct; 34(10):1960-8.
    View in: PubMed
  3. Santiago JG, Walia S, Sun JK, Cavallerano JD, Haddad ZA, Aiello LP, Silva PS. Influence of diabetes and diabetes type on anatomic and visual outcomes following central rein vein occlusion. Eye (Lond). 2014 Mar; 28(3):259-68.
    View in: PubMed
  4. Lim JI, Glassman AR, Aiello LP, Chakravarthy U, Flaxel CJ, Spaide RF. Collaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathy. Ophthalmology. 2014 May; 121(5):1073-8.
    View in: PubMed
  5. Aiello LP. Diabetic retinopathy and other ocular findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care. 2014 Jan; 37(1):17-23.
    View in: PubMed
  6. Bressler SB, Almukhtar T, Aiello LP, Bressler NM, Ferris FL, Glassman AR, Greven CM. Green or yellow laser treatment for diabetic macular edema: exploratory assessment within the Diabetic Retinopathy Clinical Research Network. Retina. 2013 Nov-Dec; 33(10):2080-8.
    View in: PubMed
  7. Silva PS, Cavallerano JD, Tolls D, Omar A, Thakore K, Patel B, Sehizadeh M, Tolson AM, Sun JK, Aiello LM, Aiello LP. Potential efficiency benefits of nonmydriatic ultrawide field retinal imaging in an ocular telehealth diabetic retinopathy program. Diabetes Care. 2014 Jan; 37(1):50-5.
    View in: PubMed
  8. Silva PS, Cavallerano JD, Sun JK, Soliman AZ, Aiello LM, Aiello LP. Peripheral lesions identified by mydriatic ultrawide field imaging: distribution and potential impact on diabetic retinopathy severity. Ophthalmology. 2013 Dec; 120(12):2587-95.
    View in: PubMed
  9. Aranda J, Motiejunaite R, Silva P, Aiello LP, Kazlauskas A. Regression activity that is naturally present in vitreous becomes ineffective as patients develop proliferative diabetic retinopathy. Diabetologia. 2013 Jun; 56(6):1444-53.
    View in: PubMed
  10. Sheetz MJ, Aiello LP, Davis MD, Danis R, Bek T, Cunha-Vaz J, Shahri N, Berg PH. The effect of the oral PKC ß inhibitor ruboxistaurin on vision loss in two phase 3 studies. Invest Ophthalmol Vis Sci. 2013 Mar; 54(3):1750-7.
    View in: PubMed
  11. Elman MJ, Qin H, Aiello LP, Beck RW, Bressler NM, Ferris FL, Glassman AR, Maturi RK, Melia M. Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results. Ophthalmology. 2012 Nov; 119(11):2312-8.
    View in: PubMed
  12. Soliman AZ, Silva PS, Aiello LP, Sun JK. Ultra-wide field retinal imaging in detection, classification, and management of diabetic retinopathy. Semin Ophthalmol. 2012 Sep-Nov; 27(5-6):221-7.
    View in: PubMed
  13. Silva PS, Walia S, Cavallerano JD, Sun JK, Dunn C, Bursell SE, Aiello LM, Aiello LP. Comparison of low-light nonmydriatic digital imaging with 35-mm ETDRS seven-standard field stereo color fundus photographs and clinical examination. Telemed J E Health. 2012 Sep; 18(7):492-9.
    View in: PubMed
  14. Al-Latayfeh M, Silva PS, Sun JK, Aiello LP. Antiangiogenic therapy for ischemic retinopathies. Cold Spring Harb Perspect Med. 2012 Jun; 2(6):a006411.
    View in: PubMed
  15. Silva PS, Cavallerano JD, Sun JK, Noble J, Aiello LM, Aiello LP. Nonmydriatic ultrawide field retinal imaging compared with dilated standard 7-field 35-mm photography and retinal specialist examination for evaluation of diabetic retinopathy. Am J Ophthalmol. 2012 Sep; 154(3):549-559.e2.
    View in: PubMed
  16. Maker MP, Noble J, Silva PS, Cavallerano JD, Murtha TJ, Sun JK, Aiello LM, Bursell SE, Aiello LP. Automated Retinal Imaging System (ARIS) compared with ETDRS protocol color stereoscopic retinal photography to assess level of diabetic retinopathy. Diabetes Technol Ther. 2012 Jun; 14(6):515-22.
    View in: PubMed
  17. Cavallerano JD, Silva PS, Tolson AM, Francis T, Tolls D, Patel B, Eagan S, Aiello LM, Aiello LP. Imager evaluation of diabetic retinopathy at the time of imaging in a telemedicine program. Diabetes Care. 2012 Mar; 35(3):482-4.
    View in: PubMed
  18. Sun JK, Qin H, Aiello LP, Melia M, Beck RW, Andreoli CM, Edwards PA, Glassman AR, Pavlica MR. Evaluation of visual acuity measurements after autorefraction vs manual refraction in eyes with and without diabetic macular edema. Arch Ophthalmol. 2012 Apr; 130(4):470-9.
    View in: PubMed
  19. Aiello LP, Beck RW, Bressler NM, Browning DJ, Chalam KV, Davis M, Ferris FL, Glassman AR, Maturi RK, Stockdale CR, Topping TM. Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema. Ophthalmology. 2011 Dec; 118(12):e5-14.
    View in: PubMed
  20. Aiello LP, Vignati L, Sheetz MJ, Zhi X, Girach A, Davis MD, Wolka AM, Shahri N, Milton RC. Oral protein kinase c ß inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C ß Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C ß Inhibitor-Diabetic Retinopathy Study 2. Retina. 2011 Nov; 31(10):2084-94.
    View in: PubMed
  21. Gangaputra S, Almukhtar T, Glassman AR, Aiello LP, Bressler N, Bressler SB, Danis RP, Davis MD. Comparison of film and digital fundus photographs in eyes of individuals with diabetes mellitus. Invest Ophthalmol Vis Sci. 2011 Aug; 52(9):6168-73.
    View in: PubMed
  22. Asato R, Kita T, Kawahara S, Arita R, Mochizuki Y, Aiello LP, Ishibashi T. Vitreous levels of soluble vascular endothelial growth factor receptor (VEGFR)-1 in eyes with vitreoretinal diseases. Br J Ophthalmol. 2011 Dec; 95(12):1745-8.
    View in: PubMed
  23. Salti H, Cavallerano JD, Salti N, Jawhari DJ, Haddad S, Sun JK, Salti I, Aiello LP. Nonmydriatic retinal image review at time of endocrinology visit results in short-term HbA1c reduction in poorly controlled patients with diabetic retinopathy. Telemed J E Health. 2011 Jul-Aug; 17(6):415-9.
    View in: PubMed
  24. Hubbard LD, Sun W, Cleary PA, Danis RP, Hainsworth DP, Peng Q, Susman RA, Aiello LP, Davis MD. Comparison of digital and film grading of diabetic retinopathy severity in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Arch Ophthalmol. 2011 Jun; 129(6):718-26.
    View in: PubMed
  25. Googe J, Brucker AJ, Bressler NM, Qin H, Aiello LP, Antoszyk A, Beck RW, Bressler SB, Ferris FL, Glassman AR, Marcus D, Stockdale CR. Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation. Retina. 2011 Jun; 31(6):1009-27.
    View in: PubMed
  26. Sheetz MJ, Aiello LP, Shahri N, Davis MD, Kles KA, Danis RP. Effect of ruboxistaurin (RBX) On visual acuity decline over a 6-year period with cessation and reinstitution of therapy: results of an open-label extension of the Protein Kinase C Diabetic Retinopathy Study 2 (PKC-DRS2). Retina. 2011 Jun; 31(6):1053-9.
    View in: PubMed
  27. Sun JK, Keenan HA, Cavallerano JD, Asztalos BF, Schaefer EJ, Sell DR, Strauch CM, Monnier VM, Doria A, Aiello LP, King GL. Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study. Diabetes Care. 2011 Apr; 34(4):968-74.
    View in: PubMed
  28. Chew EY, Glassman AR, Beck RW, Bressler NM, Fish GE, Ferris FL, Kinyoun JL. Ocular side effects associated with peribulbar injections of triamcinolone acetonide for diabetic macular edema. Retina. 2011 Feb; 31(2):284-9.
    View in: PubMed
  29. Silva PS, Cavallerano JD, Aiello LM, Aiello LP. Telemedicine and diabetic retinopathy: moving beyond retinal screening. Arch Ophthalmol. 2011 Feb; 129(2):236-42.
    View in: PubMed
  30. Danis RP, Scott IU, Qin H, Altaweel MM, Bressler NM, Bressler SB, Browning DJ, Kollman C. Association of fluorescein angiographic features with visual acuity and with optical coherence tomographic and stereoscopic color fundus photographic features of diabetic macular edema in a randomized clinical trial. Retina. 2010 Nov-Dec; 30(10):1627-37.
    View in: PubMed
  31. Sun JK, Aiello LP, Cavallerano JD, Stockman M, Miller KM, Qin H, Beck RW, Glassman AR. Visual acuity testing using autorefraction or pinhole occluder compared with a manual protocol refraction in individuals with diabetes. Ophthalmology. 2011 Mar; 118(3):537-42.
    View in: PubMed
  32. Flaxel CJ, Edwards AR, Aiello LP, Arrigg PG, Beck RW, Bressler NM, Bressler SB, Ferris FL, Gupta SK, Haller JA, Lazarus HS, Qin H. Factors associated with visual acuity outcomes after vitrectomy for diabetic macular edema: diabetic retinopathy clinical research network. Retina. 2010 Oct; 30(9):1488-95.
    View in: PubMed
  33. Al-latayfeh MM, Sun JK, Aiello LP. Ocular coherence tomography and diabetic eye disease. Semin Ophthalmol. 2010 Sep-Nov; 25(5-6):192-7.
    View in: PubMed
  34. Sanchez CR, Silva PS, Cavallerano JD, Aiello LP, Aiello LM. Ocular telemedicine for diabetic retinopathy and the Joslin Vision Network. Semin Ophthalmol. 2010 Sep-Nov; 25(5-6):218-24.
    View in: PubMed
  35. Walia S, Clermont AC, Gao BB, Aiello LP, Feener EP. Vitreous proteomics and diabetic retinopathy. Semin Ophthalmol. 2010 Sep-Nov; 25(5-6):289-94.
    View in: PubMed
  36. Keenan HA, Sun JK, Levine J, Doria A, Aiello LP, Eisenbarth G, Bonner-Weir S, King GL. Residual insulin production and pancreatic ß-cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes. 2010 Nov; 59(11):2846-53.
    View in: PubMed
  37. Silva PS, Cavallerano JD, Sun JK, Aiello LM, Aiello LP. Effect of systemic medications on onset and progression of diabetic retinopathy. Nat Rev Endocrinol. 2010 Sep; 6(9):494-508.
    View in: PubMed
  38. Kohno R, Hata Y, Mochizuki Y, Arita R, Kawahara S, Kita T, Miyazaki M, Hisatomi T, Ikeda Y, Aiello LP, Ishibashi T. Histopathology of neovascular tissue from eyes with proliferative diabetic retinopathy after intravitreal bevacizumab injection. Am J Ophthalmol. 2010 Aug; 150(2):223-229.e1.
    View in: PubMed
  39. Elman MJ, Aiello LP, Beck RW, Bressler NM, Bressler SB, Edwards AR, Ferris FL, Friedman SM, Glassman AR, Miller KM, Scott IU, Stockdale CR, Sun JK. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2010 Jun; 117(6):1064-1077.e35.
    View in: PubMed
  40. Chew EY, Kim J, Coleman HR, Aiello LP, Fish G, Ip M, Haller JA, Figueroa M, Martin D, Callanan D, Avery R, Hammel K, Thompson DJ, Ferris FL. Preliminary assessment of celecoxib and microdiode pulse laser treatment of diabetic macular edema. Retina. 2010 Mar; 30(3):459-67.
    View in: PubMed
  41. Aiello LP, Edwards AR, Beck RW, Bressler NM, Davis MD, Ferris F, Glassman AR, Ip MS, Miller KM. Factors associated with improvement and worsening of visual acuity 2 years after focal/grid photocoagulation for diabetic macular edema. Ophthalmology. 2010 May; 117(5):946-53.
    View in: PubMed
  42. Geraldes P, Hiraoka-Yamamoto J, Matsumoto M, Clermont A, Leitges M, Marette A, Aiello LP, Kern TS, King GL. Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy. Nat Med. 2009 Nov; 15(11):1298-306.
    View in: PubMed
  43. Silva PS, Cavallerano JD, Aiello LM. Ocular telehealth initiatives in diabetic retinopathy. Curr Diab Rep. 2009 Aug; 9(4):265-71.
    View in: PubMed
  44. Perkins BA, Aiello LP, Krolewski AS. Diabetes complications and the renin-angiotensin system. N Engl J Med. 2009 Jul 2; 361(1):83-5.
    View in: PubMed
  45. Kohno RI, Hata Y, Kawahara S, Kita T, Arita R, Mochizuki Y, Aiello LP, Ishibashi T. Possible contribution of hyalocytes to idiopathic epiretinal membrane formation and its contraction. Br J Ophthalmol. 2009 Aug; 93(8):1020-6.
    View in: PubMed
  46. Schwartz SG, Flynn HW, Aiello LP. Ruboxistaurin mesilate hydrate for diabetic retinopathy. Drugs Today (Barc). 2009 Apr; 45(4):269-74.
    View in: PubMed
  47. Beck RW, Edwards AR, Aiello LP, Bressler NM, Ferris F, Glassman AR, Hartnett E, Ip MS, Kim JE, Kollman C. Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol. 2009 Mar; 127(3):245-51.
    View in: PubMed
  48. Silva PS, Sun JK, Aiello LP. Role of steroids in the management of diabetic macular edema and proliferative diabetic retinopathy. Semin Ophthalmol. 2009 Mar-Apr; 24(2):93-9.
    View in: PubMed
  49. Browning DJ, Apte RS, Bressler SB, Chalam KV, Danis RP, Davis MD, Kollman C, Qin H, Sadda S, Scott IU. Association of the extent of diabetic macular edema as assessed by optical coherence tomography with visual acuity and retinal outcome variables. Retina. 2009 Mar; 29(3):300-5.
    View in: PubMed
  50. Brucker AJ, Qin H, Antoszyk AN, Beck RW, Bressler NM, Browning DJ, Elman MJ, Glassman AR, Gross JG, Kollman C, Wells JA. Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings. Arch Ophthalmol. 2009 Feb; 127(2):132-40.
    View in: PubMed
  51. Scott IU, Danis RP, Bressler S, Bressler N, Browning DJ,Qin H for the Diabetic Retinopathy Clinical Research Network. Retina. Effect of Focal/Grid Photocoagulation on Visual Acuity and Retinal Thickening in Eyes with Non-Center Involved Diabetic Macular Edema. 2009; 29(5):613-617.
  52. Browning DJ, Miller KM, Aiello LP, Beck RW, Bressler NM, Davis MD, DiLoreto DA, Ferris FL, Friedman SM, Glassman AR, Glazer LC, Kollman C, Lauer AK, Marcus DM and Star J for the Diabetic Retinopathy Clinical Research Network. Retina. The Course of Response to Focal/Grid Photocoagulation for Diabetic Macular Edema. 2009; 29:1436-1443.
  53. Girach A, Aiello LP, Milton RC, Davis MD, Danis RP, Zhi X, Sheetz MJ, Vignati L. Sustained moderate visual loss as a predictive end point for visual loss in non-proliferative diabetic retinopathy. Eye (Lond). 2009 Jan; 23(1):209-14.
    View in: PubMed
  54. Aiello LP. Time. Annual Eye Exams: Best Defense Against Vision Problems. 2008; 116.
  55. Sun JK, Aiello LP, Stockman M, Cavallerano JD, Kopple A, Eagan S, Qin H, Kollman C, Beck RW, Glassman AR. Effects of dilation on electronic-ETDRS visual acuity in diabetic patients. Invest Ophthalmol Vis Sci. 2009 Apr; 50(4):1580-4.
    View in: PubMed
  56. Browning DJ, Altaweel MM, Bressler NM, Bressler SB, Scott IU. Diabetic macular edema: what is focal and what is diffuse? Am J Ophthalmol. 2008 Nov; 146(5):649-55, 655.e1-6.
    View in: PubMed
  57. Aiello LP. Targeting intraocular neovascularization and edema--one drop at a time. N Engl J Med. 2008 Aug 28; 359(9):967-9.
    View in: PubMed
  58. Davis MD, Sheetz MJ, Aiello LP, Milton RC, Danis RP, Zhi X, Girach A, Jimenez MC, Vignati L. Effect of ruboxistaurin on the visual acuity decline associated with long-standing diabetic macular edema. Invest Ophthalmol Vis Sci. 2009 Jan; 50(1):1-4.
    View in: PubMed
  59. Sun JK, Aiello LP. Can OCT serve as a surrogate for visual acuity in eyes with DME? Curr Diab Rep. 2008 Aug; 8(4):255-6.
    View in: PubMed
  60. Browning DJ, Glassman AR, Aiello LP, Bressler NM, Bressler SB, Danis RP, Davis MD, Ferris FL, Huang SS, Kaiser PK, Kollman C, Sadda S, Scott IU, Qin H. Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. Ophthalmology. 2008 Aug; 115(8):1366-71, 1371.e1.
    View in: PubMed
  61. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology. 2008 Sep; 115(9):1447-9, 1449.e1-10.
    View in: PubMed
  62. Ip MS, Bressler SB, Antoszyk AN, Flaxel CJ, Kim JE, Friedman SM, Qin H. A randomized trial comparing intravitreal triamcinolone and focal/grid photocoagulation for diabetic macular edema: baseline features. Retina. 2008 Jul-Aug; 28(7):919-30.
    View in: PubMed
  63. Glassman AR, Beck RW, Browning DJ, Danis RP, Kollman C. Comparison of optical coherence tomography in diabetic macular edema, with and without reading center manual grading from a clinical trials perspective. Invest Ophthalmol Vis Sci. 2009 Feb; 50(2):560-6.
    View in: PubMed
  64. Gangnon RE, Davis MD, Hubbard LD, Aiello LM, Chew EY, Ferris FL, Fisher MR. A severity scale for diabetic macular edema developed from ETDRS data. Invest Ophthalmol Vis Sci. 2008 Nov; 49(11):5041-7.
    View in: PubMed
  65. Shen LQ, Child A, Weber GM, Folkman J, Aiello LP. Rosiglitazone and delayed onset of proliferative diabetic retinopathy. Arch Ophthalmol. 2008 Jun; 126(6):793-9.
    View in: PubMed
  66. Tong Z, Yang Z, Patel S, Chen H, Gibbs D, Yang X, Hau VS, Kaminoh Y, Harmon J, Pearson E, Buehler J, Chen Y, Yu B, Tinkham NH, Zabriskie NA, Zeng J, Luo L, Sun JK, Prakash M, Hamam RN, Tonna S, Constantine R, Ronquillo CC, Sadda S, Avery RL, Brand JM, London N, Anduze AL, King GL, Bernstein PS, Watkins S, Jorde LB, Li DY, Aiello LP, Pollak MR, Zhang K. Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proc Natl Acad Sci U S A. 2008 May 13; 105(19):6998-7003.
    View in: PubMed
  67. Gao BB, Chen X, Timothy N, Aiello LP, Feener EP. Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy. J Proteome Res. 2008 Jun; 7(6):2516-25.
    View in: PubMed
  68. Davis MD, Bressler SB, Aiello LP, Bressler NM, Browning DJ, Flaxel CJ, Fong DS, Foster WJ, Glassman AR, Hartnett ME, Kollman C, Li HK, Qin H, Scott IU. Comparison of time-domain OCT and fundus photographic assessments of retinal thickening in eyes with diabetic macular edema. Invest Ophthalmol Vis Sci. 2008 May; 49(5):1745-52.
    View in: PubMed
  69. Bressler NM, Edwards AR, Antoszyk AN, Beck RW, Browning DJ, Ciardella AP, Danis RP, Elman MJ, Friedman SM, Glassman AR, Gross JG, Li HK, Murtha TJ, Stone TW, Sun JK. Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy. Am J Ophthalmol. 2008 May; 145(5):894-901.
    View in: PubMed
  70. Scott IU, Bressler NM, Bressler SB, Browning DJ, Chan CK, Danis RP, Davis MD, Kollman C, Qin H. Agreement between clinician and reading center gradings of diabetic retinopathy severity level at baseline in a phase 2 study of intravitreal bevacizumab for diabetic macular edema. Retina. 2008 Jan; 28(1):36-40.
    View in: PubMed
  71. Aiello LP, Cavallerano JD, Prakash M, Aiello LM. . Principles & Practices of Ophthalmology. Diagnosis, Management and Treatment of Nonproliferative Diabetic Retinopathy and Macular Edema. 2008; 1775-1791.
  72. Sun JK, Haman R, Aiello LP. Duh EJ, ed., Diabetic Retinopathy. Clinical Trials in Protein Kinase C-beta Inhibitor in Diabetic Retinopathy. 2008; 423-434.
  73. Aiello LP. In: Larson R, Kronenberg H, Melmed S, Polonsky K, eds. Williams Textbook of Enxocrinology. Complications of Diabetes Mellitus: Diabetic Retinopathy, Macular Edema and other Ocular Complications. 2008; 1432-1443.
  74. Sun JK, Miller JW, Cavallerano JD, Aiello LP. In: Albert DM (eds) Principles and Practice of Ophthalmology. Proliferative Diabetic Retinopathy. 2008; 1807-1827.
  75. Geraldes P, Yamagata M, Rook SL, Sassa Y, Ma RC, Clermont A, Gao B, Aiello LP, Feener EP, King GL. Glypican 4, a membrane binding protein for bactericidal/permeability-increasing protein signaling pathways in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2007 Dec; 48(12):5750-5.
    View in: PubMed
  76. Bhavsar AR, Ip MS, Glassman AR. The risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE clinical trials. Am J Ophthalmol. 2007 Sep; 144(3):454-6.
    View in: PubMed
  77. Scott IU, Edwards AR, Beck RW, Bressler NM, Chan CK, Elman MJ, Friedman SM, Greven CM, Maturi RK, Pieramici DJ, Shami M, Singerman LJ, Stockdale CR. A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology. 2007 Oct; 114(10):1860-7.
    View in: PubMed
  78. Hernández-Rojas ML, Quiroz-Mercado H, Dalma-Weiszhausz J, Fromow-Guerra J, Amaya-Espinosa A, Solís-Vivanco A, Reyna-Castelán E, Abraham-Marín M, Martínez-Castellanos MA, Aiello LP. Short-term effects of intravitreal bevacizumab for subfoveal choroidal neovascularization in pathologic myopia. Retina. 2007 Jul-Aug; 27(6):707-12.
    View in: PubMed
  79. Chew E, Strauber S, Beck R, Aiello LP, Antoszyk A, Bressler N, Browning D, Danis R, Fan J, Flaxel C, Friedman S, Glassman A, Kollman C, Lazarus H. Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: a pilot study. Ophthalmology. 2007 Jun; 114(6):1190-6.
    View in: PubMed
  80. Keenan HA, Costacou T, Sun JK, Doria A, Cavellerano J, Coney J, Orchard TJ, Aiello LP, King GL. Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: the 50-year medalist study. Diabetes Care. 2007 Aug; 30(8):1995-7.
    View in: PubMed
  81. Shukla D, Aiello LP, Kolluru C, Baddela S, Jager RD, Kim R. Relation of optical coherence tomography and unusual angiographic leakage patterns in central serous chorioretinopathy. Eye (Lond). 2008 Apr; 22(4):592-6.
    View in: PubMed
  82. Fong DS, Strauber SF, Aiello LP, Beck RW, Callanan DG, Danis RP, Davis MD, Feman SS, Ferris F, Friedman SM, Garcia CA, Glassman AR, Han DP, Le D, Kollman C, Lauer AK, Recchia FM, Solomon SD. Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch Ophthalmol. 2007 Apr; 125(4):469-80.
    View in: PubMed
  83. Krzystolik MG, Strauber SF, Aiello LP, Beck RW, Berger BB, Bressler NM, Browning DJ, Chambers RB, Danis RP, Davis MD, Glassman AR, Gonzalez VH, Greenberg PB, Gross JG, Kim JE, Kollman C. Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema. Ophthalmology. 2007 Aug; 114(8):1520-5.
    View in: PubMed
  84. Gao BB, Clermont A, Rook S, Fonda SJ, Srinivasan VJ, Wojtkowski M, Fujimoto JG, Avery RL, Arrigg PG, Bursell SE, Aiello LP, Feener EP. Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. Nat Med. 2007 Feb; 13(2):181-8.
    View in: PubMed
  85. Timothy NH, Sun JK, Cavallerano JD, Gardner TW, Aiello LP. American Academy of Ophthalmology Monographs: Diabetes and Ocular Disease: Past, Present and Future Therapies. Future Therapies: Rationale for and Status of Anti-angiogenic and Anti-permeability Interventions. 2007.
  86. Gardner TW, Aiello LP. American Academy of Ophthalmolgy Monographs: Diabetes and Ocular Disease: Past, Present, and Future Therapies. Pathogenesis of Diabetic Retinopathy. 2007.
  87. Cavallerano JD, Schlossman DK, Hamam R, Aiello LP. In: Lewis Lipsitz, MD, ed. Geriatric Diabetes. Ophthalmic Complications in Older Adults with Diabetes. 2007; 221-239.
  88. The PKS-DMES Study Group. Manuscript Writing & Study Executive Committee. Aiello LP (Chair), Davis MD, Milton RC, Sheetz MJ. Arch Ophthalmolol. Effect of Ruboxistaurin, a PKC Beta Isoform-Selective Inhibitor, in Patients with Diabetic Macular Edema: 30-month Results of the Randomized PKC-DMES Clinical Trial. 2007; 125:318-324.
  89. Danis RP, Glassman AR, Aiello LP, Antoszyk AN, Beck RW, Browning DJ, Ciardella AP, Kinyoun JL, Murtha TJ, Topping TM, Shami M, Sharuk GS, Wells JA. Diurnal variation in retinal thickening measurement by optical coherence tomography in center-involved diabetic macular edema. Arch Ophthalmol. 2006 Dec; 124(12):1701-7.
    View in: PubMed
  90. Browning DJ, Glassman AR, Aiello LP, Beck RW, Brown DM, Fong DS, Bressler NM, Danis RP, Kinyoun JL, Nguyen QD, Bhavsar AR, Gottlieb J, Pieramici DJ, Rauser ME, Apte RS, Lim JI, Miskala PH. Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology. 2007 Mar; 114(3):525-36.
    View in: PubMed
  91. Yamagata M, Rook SL, Sassa Y, Ma RC, Geraldes P, Goddard L, Clermont A, Gao B, Salti H, Gundel R, White M, Feener EP, Aiello LP, King GL. Bactericidal/permeability-increasing protein's signaling pathways and its retinal trophic and anti-angiogenic effects. FASEB J. 2006 Oct; 20(12):2058-67.
    View in: PubMed
  92. Ahmed J, Ward TP, Bursell SE, Aiello LM, Cavallerano JD, Vigersky RA. The sensitivity and specificity of nonmydriatic digital stereoscopic retinal imaging in detecting diabetic retinopathy. Diabetes Care. 2006 Oct; 29(10):2205-9.
    View in: PubMed
  93. Aiello LP, Davis MD, Girach A, Kles KA, Milton RC, Sheetz MJ, Vignati L, Zhi XE. Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy. Ophthalmology. 2006 Dec; 113(12):2221-30.
    View in: PubMed
  94. Conlin PR, Fisch BM, Cavallerano AA, Cavallerano JD, Bursell SE, Aiello LM. Nonmydriatic teleretinal imaging improves adherence to annual eye examinations in patients with diabetes. J Rehabil Res Dev. 2006 Sep-Oct; 43(6):733-40.
    View in: PubMed
  95. Clermont AC, Cahill M, Salti H, Rook SL, Rask-Madsen C, Goddard L, Wong JS, Bursell D, Bursell SE, Aiello LP. Hepatocyte growth factor induces retinal vascular permeability via MAP-kinase and PI-3 kinase without altering retinal hemodynamics. Invest Ophthalmol Vis Sci. 2006 Jun; 47(6):2701-8.
    View in: PubMed
  96. Sotiropoulos KB, Clermont A, Yasuda Y, Rask-Madsen C, Mastumoto M, Takahashi J, Della Vecchia K, Kondo T, Aiello LP, King GL. Adipose-specific effect of rosiglitazone on vascular permeability and protein kinase C activation: novel mechanism for PPARgamma agonist's effects on edema and weight gain. FASEB J. 2006 Jun; 20(8):1203-5.
    View in: PubMed
  97. Chow SP, Aiello LM, Cavallerano JD, Katalinic P, Hock K, Tolson A, Kirby R, Bursell SE, Aiello LP. Comparison of nonmydriatic digital retinal imaging versus dilated ophthalmic examination for nondiabetic eye disease in persons with diabetes. Ophthalmology. 2006 May; 113(5):833-40.
    View in: PubMed
  98. Shukla D, Dhoble P, Jager RD, Aiello LP, Ramasamy K. Closure of macular hole following vitrectomy for diabetic tractional macular detachment. Eye (Lond). 2006 Dec; 20(12):1386-8.
    View in: PubMed
  99. Aiello LP. In: Diabetic Retinopathy: Focus on Diabetic Macular Edema. Advanced Studies in Ophthalmology. The Molecular Biology of Diabetic Retinopathy: Opportunities for Therapeutic Intervention. 2006; 1(3):8-12.
  100. Aiello LP, Clermont A, Arora V, Davis MD, Sheetz MJ, Bursell SE. Inhibition of PKC beta by oral administration of ruboxistaurin is well tolerated and ameliorates diabetes-induced retinal hemodynamic abnormalities in patients. Invest Ophthalmol Vis Sci. 2006 Jan; 47(1):86-92.
    View in: PubMed
  101. Whited JD, Datta SK, Aiello LM, Aiello LP, Cavallerano JD, Conlin PR, Horton MB, Vigersky RA, Poropatich RK, Challa P, Darkins AW, Bursell SE. A modeled economic analysis of a digital tele-ophthalmology system as used by three federal health care agencies for detecting proliferative diabetic retinopathy. Telemed J E Health. 2005 Dec; 11(6):641-51.
    View in: PubMed
  102. Strøm C, Sander B, Klemp K, Aiello LP, Lund-Andersen H, Larsen M. Effect of ruboxistaurin on blood-retinal barrier permeability in relation to severity of leakage in diabetic macular edema. Invest Ophthalmol Vis Sci. 2005 Oct; 46(10):3855-8.
    View in: PubMed
  103. Cunningham ET, Adamis AP, Altaweel M, Aiello LP, Bressler NM, D'Amico DJ, Goldbaum M, Guyer DR, Katz B, Patel M, Schwartz SD. A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology. 2005 Oct; 112(10):1747-57.
    View in: PubMed
  104. Aiello LP. Angiogenic pathways in diabetic retinopathy. N Engl J Med. 2005 Aug 25; 353(8):839-41.
    View in: PubMed
  105. Cavallerano JD, Aiello LP, Cavallerano AA, Katalinic P, Hock K, Kirby R, Aiello LM. Nonmydriatic digital imaging alternative for annual retinal examination in persons with previously documented no or mild diabetic retinopathy. Am J Ophthalmol. 2005 Oct; 140(4):667-73.
    View in: PubMed
  106. The PKC-DRS Group (Aiello LP). The Effect of Ruboxistaurin on Visual Loss in Patients with Moderately Severe to Very Severe Nonproliferative Diabetic Retinopathy. Initial Results of the Protein Kinase C Beta Inhibitor Diabetic Retinopathy Study (PKC-DRS) Multicenter Randomized Clinical Trial. Diabetes. 2005; 54:2188-2197.
  107. Jager RD, Timothy NH, Coney JM, Katalinic P, Cavicchi RW, Strong J, Cavallerano JD, Aiello LP. Congenital retinal macrovessel. Retina. 2005 Jun; 25(4):538-40.
    View in: PubMed
  108. Cavallerano AA, Cavallerano JD, Katalinic P, Blake B, Rynne M, Conlin PR, Hock K, Tolson AM, Aiello LP, Aiello LM. A telemedicine program for diabetic retinopathy in a Veterans Affairs Medical Center--the Joslin Vision Network Eye Health Care Model. Am J Ophthalmol. 2005 Apr; 139(4):597-604.
    View in: PubMed
  109. Aiello LP. Eyes on the Prize: Preventing Vision Problems Associated with Diabetes. 2005.
  110. Wilson C, Horton M, Cavallerano J, Aiello LM. Addition of primary care-based retinal imaging technology to an existing eye care professional referral program increased the rate of surveillance and treatment of diabetic retinopathy. Diabetes Care. 2005 Feb; 28(2):318-22.
    View in: PubMed
  111. Aiello LP. Eye Complications of Diabetes (edited). 2005.
  112. Aiello LP. Molecular Biology and Natural History of Diabetic Retinopathy. Advanced Studies in Ophthalmology. 2005; 2(1):8-13.
  113. Gardner TW, Aiello LP. In: Scott, ed. Diabetic Retinopathy: A Practical Guide for the Clinical Ophthalmologist. Pathogenesis of Diabetic Retinopathy. 2005.
  114. Cavallerano J, Aiello LM. Emerging trends in ocular telemedicine: the diabetic retinopathy model. J Telemed Telecare. 2005; 11(4):163-6.
    View in: PubMed
  115. Aiello LM, Aiello LP, Cavallerano JD. In: Kahn CR, Weir GC, King GL, Jacobson AM, Moses AC, Smith RJ (ed). Joslin's Diabetes Mellitus. Ocular complications of diabetes mellitus. 2005; 901-924.
  116. Aiello LP, Cavallerano J, Klein R. In: Leslie J. DeGroot, J. Larry Jameson, eds. Endocrinology. Diabetic Eye Disease. 2005; 1305-1317.
  117. Aiello LP. Advanced Studies in Medicine. Molecular Biology and Natural History of Diabetic Retinopathy. 2005; 1(2):8-13.
  118. Aiello LP, Cavallerano JD. Diabetic Retinopathy. Johnstone MT, Veves A. (ed.). Diabetes and Cardiovascular Disease. 2005; 349-365.
  119. Fong DS, Aiello LP, Ferris FL, Klein R. Diabetic retinopathy. Diabetes Care. 2004 Oct; 27(10):2540-53.
    View in: PubMed
  120. Aiello LP, Brucker AJ, Chang S, Cunningham ET, D'Amico DJ, Flynn HW, Grillone LR, Hutcherson S, Liebmann JM, O'Brien TP, Scott IU, Spaide RF, Ta C, Trese MT. Evolving guidelines for intravitreous injections. Retina. 2004 Oct; 24(5 Suppl):S3-19.
    View in: PubMed
  121. Jager RD, Aiello LP, Patel SC, Cunningham ET. Risks of intravitreous injection: a comprehensive review. Retina. 2004 Oct; 24(5):676-98.
    View in: PubMed
  122. Sassa Y, Hata Y, Aiello LP, Taniguchi Y, Kohno K, Ishibashi T. Bifunctional properties of peroxisome proliferator-activated receptor gamma1 in KDR gene regulation mediated via interaction with both Sp1 and Sp3. Diabetes. 2004 May; 53(5):1222-9.
    View in: PubMed
  123. Aiello LP, Cahill MT, Cavallerano JD. Growth factors and protein kinase C inhibitors as novel therapies for the medical management diabetic retinopathy. Eye (Lond). 2004 Feb; 18(2):117-25.
    View in: PubMed
  124. Aiello LP, Aiello LM, Cavallerano JD. Visual Loss. Therapy for Diabetes Melliltus and Related Disorders. 2004; 37:340-343.
  125. Grand MG, Aiello LP, Cavallerano JD, Iwamoto MA. Eye Disease. Levine, Pfeiffer eds. The Uncomplicated Guide to Diabetes Complications. 2004; in press.
  126. Aiello LP, Cahill MT. Novel therapies for the medical management of diabetic retinopathy. Eye. 2004.
  127. Salti H, Cavallerano JD, Cahill MT, Wong JS, Aiello LP. Influence of blood pressure and blood glucose control on diabetic retinopathy. A Review. Hypertension and Diabetes. 2004; 2:in press.
  128. Aiello LP, Aiello LM, Cavallerano JD. Ocular Complications. Therapy for Diabetes Mellitus and Related Disorders. 2004; 38:344-357.
  129. Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL, Klein R. Retinopathy in diabetes. Diabetes Care. 2004 Jan; 27 Suppl 1:S84-7.
    View in: PubMed
  130. Cavallerano J, Lawrence MG, Zimmer-Galler I, Bauman W, Bursell S, Gardner WK, Horton M, Hildebrand L, Federman J, Carnahan L, Kuzmak P, Peters JM, Darkins A, Ahmed J, Aiello LM, Aiello LP, Buck G, Cheng YL, Cunningham D, Goodall E, Hope N, Huang E, Hubbard L, Janczewski M, Lewis JW, Matsuzaki H, McVeigh FL, Motzno J, Parker-Taillon D, Read R, Soliz P, Szirth B, Vigersky RA, Ward T. Telehealth practice recommendations for diabetic retinopathy. Telemed J E Health. 2004; 10(4):469-82.
    View in: PubMed
  131. Aiello LM. Perspectives on diabetic retinopathy. Am J Ophthalmol. 2003 Jul; 136(1):122-35.
    View in: PubMed
  132. Cavallerano AA, Cavallerano JD, Katalinic P, Tolson AM, Aiello LP, Aiello LM. Use of Joslin Vision Network digital-video nonmydriatic retinal imaging to assess diabetic retinopathy in a clinical program. Retina. 2003 Apr; 23(2):215-23.
    View in: PubMed
  133. Fong DS, Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL, Klein R. Diabetic Retinopathy. American Diabetes Association Position Statement. 2003; 26(1):226-229.
  134. Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL, Klein R. Diabetic retinopathy. Diabetes Care. 2003 Jan; 26(1):226-9.
    View in: PubMed
  135. Aiello LP. Eye Complications of Diabetes. Skyler, ed. Atlas of Diabetes. 2003.
  136. Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL, Klein R. Diabetic retinopathy. Diabetes Care. 2003 Jan; 26 Suppl 1:S99-S102.
    View in: PubMed
  137. Aiello LP. The potential role of PKC beta in diabetic retinopathy and macular edema. Surv Ophthalmol. 2002 Dec; 47 Suppl 2:S263-9.
    View in: PubMed
  138. Joussen AM, Poulaki V, Mitsiades N, Cai WY, Suzuma I, Pak J, Ju ST, Rook SL, Esser P, Mitsiades CS, Kirchhof B, Adamis AP, Aiello LP. Suppression of Fas-FasL-induced endothelial cell apoptosis prevents diabetic blood-retinal barrier breakdown in a model of streptozotocin-induced diabetes. FASEB J. 2003 Jan; 17(1):76-8.
    View in: PubMed
  139. Aiello LP, George DJ, Cahill MT, Wong JS, Cavallerano J, Hannah AL, Kaelin WG. Rapid and durable recovery of visual function in a patient with von hippel-lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor su5416. Ophthalmology. 2002 Sep; 109(9):1745-51.
    View in: PubMed
  140. Duh EJ, Yang HS, Suzuma I, Miyagi M, Youngman E, Mori K, Katai M, Yan L, Suzuma K, West K, Davarya S, Tong P, Gehlbach P, Pearlman J, Crabb JW, Aiello LP, Campochiaro PA, Zack DJ. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Invest Ophthalmol Vis Sci. 2002 Mar; 43(3):821-9.
    View in: PubMed
  141. Rauniyar RK, Suzuma K, King AL, Aiello LP, King GL. Differential effects of bactericidal/permeability-increasing protein (BPI) analogues on retinal neovascularization and retinal pericyte growth. Invest Ophthalmol Vis Sci. 2002 Feb; 43(2):503-9.
    View in: PubMed
  142. Chou E, Suzuma I, Way KJ, Opland D, Clermont AC, Naruse K, Suzuma K, Bowling NL, Vlahos CJ, Aiello LP, King GL. Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic States: a possible explanation for impaired collateral formation in cardiac tissue. Circulation. 2002 Jan 22; 105(3):373-9.
    View in: PubMed
  143. Suzuma K, Takahara N, Suzuma I, Isshiki K, Ueki K, Leitges M, Aiello LP, King GL. Characterization of protein kinase C beta isoform's action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proliferation, and retinal neovascularization. Proc Natl Acad Sci U S A. 2002 Jan 22; 99(2):721-6.
    View in: PubMed
  144. Suzama I, Hata Y, Clermont A, Pokras F, Rook S, Suzuma K, Feener E, Aiello LP. Cyclic Stretch and Hypertension Induce Retinal Expression of Vascular Endothelial Growth Factor Receptor-2: Potential Mechanisms for Exacerbation of Diabetic Retinopathy in Hypertension. Focus on Diabetic Retinopathy. 2002; 9(1):15-18.
  145. Duh E, Aiello LP. Basic Pathobiology of the Eye and Its Complications. Porte D, ed. Ellenberg & Refkin's Diabetes. 2002; 653-661.
  146. Suzuma I, Suzuma K, Ueki K, Hata Y, Feener EP, King GL, Aiello LP. Stretch-induced retinal vascular endothelial growth factor expression is mediated by phosphatidylinositol 3-kinase and protein kinase C (PKC)-zeta but not by stretch-induced ERK1/2, Akt, Ras, or classical/novel PKC pathways. J Biol Chem. 2002 Jan 11; 277(2):1047-57.
    View in: PubMed
  147. Aiello LP, Cahill MT, Wong JS. Systemic considerations in the management of diabetic retinopathy. Am J Ophthalmol. 2001 Nov; 132(5):760-76.
    View in: PubMed
  148. Aiello; Lloyd Paul, Jirousek; Michael R, King; George L, Vignati; Louis, Ways; Douglas Kirk . Therapeutic treatment for VEGF related diseases Therapeutic treatment for VEGF related diseases Therapeutic treatment for VEGF related diseases. 2001.
  149. Chaturvedi N, Fuller JH, Pokras F, Rottiers R, Papazoglou N, Aiello LP. Circulating plasma vascular endothelial growth factor and microvascular complications of type 1 diabetes mellitus: the influence of ACE inhibition. Diabet Med. 2001 Apr; 18(4):288-94.
    View in: PubMed
  150. Bursell SE, Cavallerano JD, Cavallerano AA, Clermont AC, Birkmire-Peters D, Aiello LP, Aiello LM. Stereo nonmydriatic digital-video color retinal imaging compared with Early Treatment Diabetic Retinopathy Study seven standard field 35-mm stereo color photos for determining level of diabetic retinopathy. Ophthalmology. 2001 Mar; 108(3):572-85.
    View in: PubMed
  151. Suzuma I, Hata Y, Clermont A, Pokras F, Rook SL, Suzuma K, Feener EP, Aiello LP. Cyclic stretch and hypertension induce retinal expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2: potential mechanisms for exacerbation of diabetic retinopathy by hypertension. Diabetes. 2001 Feb; 50(2):444-54.
    View in: PubMed
  152. Aiello LP, Cavallerano J. Diabetic Retinopathy. Johnstone MT and Vevas A, eds. Contemporary Cardiology: Diabetes and Cardiovascular Disease. 2001; Chapter 21:385-398.
  153. Aiello LP, Wong J, Cavallerano J, Bursell SE, Aiello LM. Retinopathy. Rugerman N, Devlin JT, Kriska A, eds. Handbook of Exercise in Diabetes. 2001.
  154. Suzuma K, Naruse K, Suzuma I, Takahara N, Ueki K, Aiello LP, King GL. Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells. J Biol Chem. 2000 Dec 29; 275(52):40725-31.
    View in: PubMed
  155. Wong JS, Aiello LP. Diabetic retinopathy. Ann Acad Med Singapore. 2000 Nov; 29(6):745-52.
    View in: PubMed
  156. Feng D, Bursell SE, Clermont AC, Lipinska I, Aiello LP, Laffel L, King GL, Tofler GH. von Willebrand factor and retinal circulation in early-stage retinopathy of type 1 diabetes. Diabetes Care. 2000 Nov; 23(11):1694-8.
    View in: PubMed
  157. Aiello; Lloyd P, Jirousek; Michael R, King; George L, Vignati; Louis, Ways; Douglas Kirk . Therapeutic treatment for VEGF related ocular diseases. 2000.
  158. Aiello LP, Wong JS. Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int Suppl. 2000 Sep; 77:S113-9.
    View in: PubMed
  159. Hata Y, Clermont A, Yamauchi T, Pierce EA, Suzuma I, Kagokawa H, Yoshikawa H, Robinson GS, Ishibashi T, Hashimoto T, Umeda F, Bursell SE, Aiello LP. Retinal expression, regulation, and functional bioactivity of prostacyclin-stimulating factor. J Clin Invest. 2000 Aug; 106(4):541-50.
    View in: PubMed
  160. Cai W, Rook SL, Jiang ZY, Takahara N, Aiello LP. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth. Invest Ophthalmol Vis Sci. 2000 Jun; 41(7):1885-93.
    View in: PubMed
  161. Miyamoto K, Khosrof S, Bursell SE, Moromizato Y, Aiello LP, Ogura Y, Adamis AP. Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). Am J Pathol. 2000 May; 156(5):1733-9.
    View in: PubMed
  162. Aiello LP. Keeping in touch with angiogenesis. Nat Med. 2000 Apr; 6(4):379-81.
    View in: PubMed
  163. Barouch FC, Miyamoto K, Allport JR, Fujita K, Bursell SE, Aiello LP, Luscinskas FW, Adamis AP. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. Invest Ophthalmol Vis Sci. 2000 Apr; 41(5):1153-8.
    View in: PubMed
  164. Aiello, Lloyd P. LPA: THESIS TITLE AS WELL AS DATE PUBLISHED. 2000.
  165. Aiello LP, Gardner TW. Future Therapies for Diabetic Retinopathy. Diabetes and Ocular Disease: Past, Present, and Future Therapies. 2000; 14:239-274.
  166. Aiello LP, Wong JS. Kidney International. Role of Vascular Endothelial Growth Factor in Diabetic Vascular Complications. 2000; 58 Supp 77:S113-S119.
  167. Gardner TW, Aiello LP. Pathogenesis of Diabetic Retinopathy. Diabetes and Ocular Disease: past, Present, and Future Therapies. 2000; 14:1-18.
  168. Duh E, Aiello LP. Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. Diabetes. 1999 Oct; 48(10):1899-906.
    View in: PubMed
  169. Miyamoto K, Khosrof S, Bursell SE, Rohan R, Murata T, Clermont AC, Aiello LP, Ogura Y, Adamis AP. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci U S A. 1999 Sep 14; 96(19):10836-41.
    View in: PubMed
  170. Espaillat A, Aiello LP, Calderon RM, Cavallerano JD, Cavicchi RW, Cordahi G. Preservation of vision through Weiss ring after dense vitreous hemorrhage. Am J Ophthalmol. 1999 Sep; 128(3):376-8.
    View in: PubMed
  171. Ferris FL, Davis MD, Aiello LM. Treatment of diabetic retinopathy. N Engl J Med. 1999 Aug 26; 341(9):667-78.
    View in: PubMed
  172. Bursell SE, Clermont AC, Aiello LP, Aiello LM, Schlossman DK, Feener EP, Laffel L, King GL. High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care. 1999 Aug; 22(8):1245-51.
    View in: PubMed
  173. Hata Y, Rook SL, Aiello LP. Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway. Diabetes. 1999 May; 48(5):1145-55.
    View in: PubMed
  174. Espaillat A, Aiello LP, Arrigg PG, Villalobos R, Silver PM, Cavicchi RW. Canthaxanthine retinopathy. Arch Ophthalmol. 1999 Mar; 117(3):412-3.
    View in: PubMed
  175. Adamis AP, Aiello LP, D'Amato RA. Angiogenesis and ophthalmic disease. Angiogenesis. 1999; 3(1):9-14.
    View in: PubMed
  176. Aiello LP. Eye Complications of Diabetes. Koreman, Kahn CR, eds. Atlas of Clinical Endocrinology Volume II: Diabetes. 1999; II.
  177. Aiello LP, Hata Y. Molecular Mechanisms of Growth Factor Action in Diabetic Retinopathy. Current Opinion Endocrinology and Diabetes. 1999; 6:146-156.
  178. Espaillat E, Cavallerano JD, Aiello LP. How to do a Better Dilated Fundus Exam in Diabetic Patients. Rev. Ophthalmol. 1999; VI(8):52-59.
  179. Actor. "Managed Care in America". PBS-TV program aired in 2000. 1999.
  180. Vasir B, Aiello LP, Yoon KH, Quickel RR, Bonner-Weir S, Weir GC. Hypoxia induces vascular endothelial growth factor gene and protein expression in cultured rat islet cells. Diabetes. 1998 Dec; 47(12):1894-903.
    View in: PubMed
  181. Aiello LM, Bursell SE, Cavallerano J, Gardner WK, Strong J. Joslin Vision Network Validation Study: pilot image stabilization phase. J Am Optom Assoc. 1998 Nov; 69(11):699-710.
    View in: PubMed
  182. Takagi H, King GL, Aiello LP. Hypoxia upregulates glucose transport activity through an adenosine-mediated increase of GLUT1 expression in retinal capillary endothelial cells. Diabetes. 1998 Sep; 47(9):1480-8.
    View in: PubMed
  183. Hata Y, Duh E, Zhang K, Robinson GS, Aiello LP. Transcription factors Sp1 and Sp3 alter vascular endothelial growth factor receptor expression through a novel recognition sequence. J Biol Chem. 1998 Jul 24; 273(30):19294-303.
    View in: PubMed
  184. Schuppin GT, Pons S, Hügl S, Aiello LP, King GL, White M, Rhodes CJ. A specific increased expression of insulin receptor substrate 2 in pancreatic beta-cell lines is involved in mediating serum-stimulated beta-cell growth. Diabetes. 1998 Jul; 47(7):1074-85.
    View in: PubMed
  185. Davis MD, Fisher MR, Gangnon RE, Barton F, Aiello LM, Chew EY, Ferris FL, Knatterud GL. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Invest Ophthalmol Vis Sci. 1998 Feb; 39(2):233-52.
    View in: PubMed
  186. Aiello LM, Bursell SE, Cavallerano J, Gardner WK, Strong J and The Joslin Vision Network Research Team. J. Am. Optometric Assoc. Joslin Vision Network Validation Study: Pilot Image Stabilization Phase. 1998; 69(11):699-710.
  187. Grand MG, Aiello LP, Cavallerano JD, Iwamoto MA. Eye Disease. The Uncomplicated Guide to Diabetes Complications. 1998; 67-99.
  188. Aiello LM, Cavallerano J, Aiello LP, Bursell SE. Diabetic Retinopathy. Guyer D, Yannuzzi L, Chang S, Shields B, Green WR, eds. Retina-Vitreous-Macula. 1998; 316-344.
  189. Robinson GS, Aiello LP. Angiogenic factors in diabetic ocular disease: mechanisms of today, therapies for tomorrow. Int Ophthalmol Clin. 1998; 38(2):89-102.
    View in: PubMed
  190. Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL, Klein R. Diabetic retinopathy. Diabetes Care. 1998 Jan; 21(1):143-56.
    View in: PubMed
  191. Aiello LP. Angiogenesis in diabetic retinopathy : a history of accomplishment, discovery and promise. Diabetic Renal-Retinal Syndrome: 21st Century Management Now. 1998; 181-196.
  192. Kubaska SM, Phaneuf MD, Rook SL, Aiello LP, LoGerfo FW, Quist WC. Characterization of covalently bound vascular endothelial growth factor: creation of a novel dacron prosthetic graft surface. Surgical Forum. 1998; 322-324.
  193. Clermont AC, Aiello LP, Mori F, Aiello LM, Bursell SE. Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy. Am J Ophthalmol. 1997 Oct; 124(4):433-46.
    View in: PubMed
  194. Aiello LP, Bursell SE, Clermont A, Duh E, Ishii H, Takagi C, Mori F, Ciulla TA, Ways K, Jirousek M, Smith LE, King GL. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes. 1997 Sep; 46(9):1473-80.
    View in: PubMed
  195. Aiello LP. Vascular endothelial growth factor. 20th-century mechanisms, 21st-century therapies. Invest Ophthalmol Vis Sci. 1997 Aug; 38(9):1647-52.
    View in: PubMed
  196. Hamdan AD, Aiello LP, Misare BD, Contreras MA, King GL, LoGerfo FW, Quist WC. Vascular endothelial growth factor expression in canine peripheral vein bypass grafts. J Vasc Surg. 1997 Jul; 26(1):79-86.
    View in: PubMed
  197. Aiello LP. Clinical implications of vascular growth factors in proliferative retinopathies. Curr Opin Ophthalmol. 1997 Jun; 8(3):19-31.
    View in: PubMed
  198. Aiello LP. Ophthalmic Research. Vascular Endothelial Growth Factor and the Eye: Biochemical Mechanisms of Action and Implications for Novel Therapies. 1997; 29:354-362.
  199. Takagi H, King GL, Aiello LP. Identification and Characterization of Vascular Endothelial Growth Factor Receptor (Flt) in Bovine Retinal Pericytes. Focus on Diabetic Retinopathy. 1997; 4:41-42.
  200. Aiello LM, Cavallerano J. Diabetic retinopathy. Curr Ther Endocrinol Metab. 1997; 6:475-85.
    View in: PubMed
  201. Aiello LP. Ophthalmic Drug Formulary. Varma R, ed. Essentials of Eye Care: The Johns Hopkins Wilmer Handbook. 1997; 643-678.
  202. Aiello LP. Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications for novel therapies. Ophthalmic Res. 1997; 29(5):354-62.
    View in: PubMed
  203. Xia P, Aiello LP, Ishii H, Jiang ZY, Park DJ, Robinson GS, Takagi H, Newsome WP, Jirousek MR, King GL. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest. 1996 Nov 1; 98(9):2018-26.
    View in: PubMed
  204. Takagi H, King GL, Robinson GS, Ferrara N, Aiello LP. Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells. Invest Ophthalmol Vis Sci. 1996 Oct; 37(11):2165-76.
    View in: PubMed
  205. Aiello LP. Vascular endothelial growth factor and the eye. Past, present and future. Arch Ophthalmol. 1996 Oct; 114(10):1252-4.
    View in: PubMed
  206. Takagi H, King GL, Aiello LP. Identification and characterization of vascular endothelial growth factor receptor (Flt) in bovine retinal pericytes. Diabetes. 1996 Aug; 45(8):1016-23.
    View in: PubMed
  207. Takagi H, King GL, Ferrara N, Aiello LP. Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells. Invest Ophthalmol Vis Sci. 1996 Jun; 37(7):1311-21.
    View in: PubMed
  208. Aiello LP, Cavallerano J, Bursell SE. Diabetic eye disease. Endocrinol Metab Clin North Am. 1996 Jun; 25(2):271-91.
    View in: PubMed
  209. Bursell SE, Clermont AC, Kinsley BT, Simonson DC, Aiello LM, Wolpert HA. Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy. Invest Ophthalmol Vis Sci. 1996 Apr; 37(5):886-97.
    View in: PubMed
  210. Aiello LP. Arch. Ophthalmology [letter]. Lightning-induced Ocular Injury. 1996; 114(4):501-502.
  211. Javitt JC, Aiello LP. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med. 1996 Jan 1; 124(1 Pt 2):164-9.
    View in: PubMed
  212. Aiello LP. Implications for Novel Growth Factor Therapies in Diabetic Retinopathy. Current Opinion in Endocrinology and Diabetes. 1996; 3:307-314.
  213. Aiello LP. VEGF and the Eye: Past, Present and Future. Arch Ophthalmol. 1996; 114(10):1252-1254.
  214. Aiello LP, Northrup JM, Keyt BA, Takagi H, Iwamoto MA. Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol. 1995 Dec; 113(12):1538-44.
    View in: PubMed
  215. Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, Ferrara N, King GL, Smith LE. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci U S A. 1995 Nov 7; 92(23):10457-61.
    View in: PubMed
  216. Nishio Y, Warren CE, Buczek-Thomas JA, Rulfs J, Koya D, Aiello LP, Feener EP, Miller TB, Dennis JW, King GL. Identification and characterization of a gene regulating enzymatic glycosylation which is induced by diabetes and hyperglycemia specifically in rat cardiac tissue. J Clin Invest. 1995 Oct; 96(4):1759-67.
    View in: PubMed
  217. Fong DS, Warram JH, Aiello LM, Rand LI, Krolewski AS. Cardiovascular autonomic neuropathy and proliferative diabetic retinopathy. Am J Ophthalmol. 1995 Sep; 120(3):317-21.
    View in: PubMed
  218. Lagrèze WD, Bömer TG, Aiello LP. Lightning-induced ocular injury. Arch Ophthalmol. 1995 Aug; 113(8):1076-7.
    View in: PubMed
  219. Feener EP, Northrup JM, Aiello LP, King GL. Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells. J Clin Invest. 1995 Mar; 95(3):1353-62.
    View in: PubMed
  220. Hamdan AD, Aiello LP, Quist WC, Ozaki CK, Contreras MA, Phaneuf MD, Ruiz C, King GL, LoGerfo FW. Isolation of genes differentially expressed at the downstream anastomosis of prosthetic arterial grafts with use of mRNA differential display. J Vasc Surg. 1995 Feb; 21(2):228-34.
    View in: PubMed
  221. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A. 1995 Jan 31; 92(3):905-9.
    View in: PubMed
  222. Aiello LP, Arrigg PG, Aiello LM. Reversible leukocoria associated with clinically significant diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 1995 Jan; 233(1):54-5.
    View in: PubMed
  223. Aiello LM, Cavallerano J, Aiello LP, Bursell SE. Exercise in Patients with Diabetic Complications: Retinopathy. Ruderman, N, Devlin JT, eds. The Health Professional's Guide to Diabetes and Exercise. 1995; 143-151.
  224. Thieme H, Aiello LP, Takagi H, Ferrara N, King GL. Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells. Diabetes. 1995 Jan; 44(1):98-103.
    View in: PubMed
  225. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994 Dec 1; 331(22):1480-7.
    View in: PubMed
  226. Javitt JC, Aiello LP, Chiang Y, Ferris FL, Canner JK, Greenfield S. Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform. Diabetes Care. 1994 Aug; 17(8):909-17.
    View in: PubMed
  227. Aiello LP, Arrigg PG, Shah ST, Murtha TJ, Aiello LM. Solar retinopathy associated with hypoglycemic insulin reaction. Arch Ophthalmol. 1994 Jul; 112(7):982-3.
    View in: PubMed
  228. Aiello LP, Robinson GS, Lin YW, Nishio Y, King GL. Identification of multiple genes in bovine retinal pericytes altered by exposure to elevated levels of glucose by using mRNA differential display. Proc Natl Acad Sci U S A. 1994 Jun 21; 91(13):6231-5.
    View in: PubMed
  229. Aiello LM, Cavallerano J. Diabetic retinopathy. Curr Ther Endocrinol Metab. 1994; 5:436-46.
    View in: PubMed
  230. Nishio Y, Aiello LP, King GL. Glucose induced genes in bovine aortic smooth muscle cells identified by mRNA differential display. FASEB J. 1994 Jan; 8(1):103-6.
    View in: PubMed
  231. Aiello LP, Javitt JC, Canner JK. National outcomes of penetrating keratoplasty. Risks of endophthalmitis and retinal detachment. Arch Ophthalmol. 1993 Apr; 111(4):509-13.
    View in: PubMed
  232. Aiello LP, Traboulsi EI. Pigmented fundus lesions in a preterm infant with familial adenomatous polyposis. Arch Ophthalmol. 1993 Mar; 111(3):302-3.
    View in: PubMed
  233. Aiello LP, Iwamoto M, Guyer DR. Penetraing Ocular Fishhook Injuries: Surgical Management and Long-term Visual Outcome. Ophthalmology Digest. 1993; 5:30-31.
  234. Aiello LP, Iwamoto M, Taylor HR. Removing Penetrating Fishhooks. Arch. Ophthalmology. 1993; 111(4):429-30.
  235. Aiello LP, Iwamoto M, Taylor HR. Perforating ocular fishhook injury. Arch Ophthalmol. 1992 Sep; 110(9):1316-7.
    View in: PubMed
  236. Aiello LP, Iwamoto M, Guyer DR. Penetrating ocular fish-hook injuries. Surgical management and long-term visual outcome. Ophthalmology. 1992 Jun; 99(6):862-6.
    View in: PubMed
  237. Javitt JC, Aiello LP, Bassi LJ, Chiang YP, Canner JK. Detecting and treating retinopathy in patients with type I diabetes mellitus. Savings associated with improved implementation of current guidelines. American Academy of Ophthalmology. Ophthalmology. 1991 Oct; 98(10):1565-73; discussion 1574.
    View in: PubMed
  238. Aiello LP, Schachat AP. Choroidal Metastasis. Falco L, Esente S, eds. Tumori Intraoculari: International Symposium on Intraocular Tumors. 1990; 79-84.
  239. Actor. Evaluation and treatment of diabetic retinopathy (COVE Diabetic Retinopathy Videotape). 1990.
  240. Gottsch JD, Aiello LP. Hyphema: Diagnosis and Management. Ophthalmology Digest. 1990; 5:8-9.
  241. Aiello LP. Management of Diabetic Retinopathy for the Primary Care Physician. 1990.
  242. Kinyoun J, Barton F, Fisher M, Hubbard L, Aiello L, Ferris F. Detection of diabetic macular edema. Ophthalmoscopy versus photography--Early Treatment Diabetic Retinopathy Study Report Number 5. The ETDRS Research Group. Ophthalmology. 1989 Jun; 96(6):746-50; discussion 750-1.
    View in: PubMed
  243. Aiello LP, Shia MA, Robinson GS, Pilch PF, Farmer SR. Characterization and hepatic expression of rat alpha 1-inhibitor III mRNA. J Biol Chem. 1988 Mar 15; 263(8):4013-22.
    View in: PubMed
  244. Aiello LM, Ferris FL. Photocoagulation for diabetic macular edema. Arch Ophthalmol. 1987 Sep; 105(9):1163.
    View in: PubMed
  245. Baker RS, Rand LI, Krolewski AS, Maki T, Warram JH, Aiello LM. Influence of HLA-DR phenotype and myopia on the risk of nonproliferative and proliferative diabetic retinopathy. Am J Ophthalmol. 1986 Dec 15; 102(6):693-700.
    View in: PubMed
  246. Aiello LP, Wessling-Resnick M, Pilch PF. Dipeptide metalloendoprotease substrates are glucose transport inhibitors and membrane structure perturbants. Biochemistry. 1986 Jul 1; 25(13):3944-50.
    View in: PubMed
  247. Rand LI, Krolewski AS, Aiello LM, Warram JH, Baker RS, Maki T. Multiple factors in the prediction of risk of proliferative diabetic retinopathy. N Engl J Med. 1985 Dec 5; 313(23):1433-8.
    View in: PubMed
  248. Aiello LM, Wand M, Liang G. Neovascular glaucoma and vitreous hemorrhage following cataract surgery in patients with diabetes mellitus. Ophthalmology. 1983 Jul; 90(7):814-20.
    View in: PubMed
  249. Aiello LM, Rand LI, Briones JC, Wafai MZ, Sebestyen JG. Diabetic retinopathy in Joslin Clinic patients with adult-onset diabetes. Ophthalmology. 1981 Jul; 88(7):619-23.
    View in: PubMed
  250. Pavan PR, Aiello LM, Wafai MZ, Briones JC, Sebestyen JG, Bradbury MJ. Optic disc edema in juvenile-onset diabetes. Arch Ophthalmol. 1980 Dec; 98(12):2193-5.
    View in: PubMed
  251. Ghartey KN, Tolentino FI, Freeman HM, McMeel JW, Schepens CL, Aiello LM. Closed vitreous surgery. XVII. Results and complications of pars plana vitrectomy. Arch Ophthalmol. 1980 Jul; 98(7):1248-52.
    View in: PubMed
  252. Abourizk N, Ishaq Arastu M, Arora T, Briones JC, Kaldany A, Aiello LM, D'Elia JA. Ocular surgery in patients with diabetic nephropathy. Diabetes Care. 1980 Jul-Aug; 3(4):530-2.
    View in: PubMed
  253. Wand M, Dueker DK, Aiello LM, Grant WM. Effects of panretinal photocoagulation on rubeosis iridis, angle neovascularization, and neovascular glaucoma. Am J Ophthalmol. 1978 Sep; 86(3):332-9.
    View in: PubMed
  254. Aiello LM, Briones JC. Ruby laser photocoagulation of proliferating diabetic retinopathy: fifth-year followup. Int Ophthalmol Clin. 1976; 16(4):15-27.
    View in: PubMed
  255. Okisaka S, Kuwabara T, Aiello LM. The effects of laser photocoagulation in the retinal capillaries. Am J Ophthalmol. 1975 Oct; 80(4):591-601.
    View in: PubMed
  256. Bouzas AG, Gragoudas ES, Balodimos MC, Brinegar CH, Aiello LM. Intraocular pressure in diabetes. Relationship to retinopathy and blood glucose level. Arch Ophthalmol. 1971 Apr; 85(4):423-7.
    View in: PubMed
  257. Beetham WP, Aiello LM, Balodimos MC, Koncz L. Ruby laser photocoagulation of early diabetic neovascular retinopathy. Preliminary report of a long-term controlled study. Arch Ophthalmol. 1970 Mar; 83(3):261-72.
    View in: PubMed
  258. Balodimos MC, Aiello LM, Gleason RE, Marble A. Retinopathy in mild diabetes of long duration. Arch Ophthalmol. 1969 May; 81(5):660-6.
    View in: PubMed
  259. Beetham WP, Aiello LM, Balodimos MC, Koncz L. Ruby-laser photocoagulation of early diabetic neovascular retinopathy: preliminary report of a long-term controlled study. Trans Am Ophthalmol Soc. 1969; 67:39-67.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Aiello's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_